# Emergent BioSolutions Inc. (EBS) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Emergent BioSolutions Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/EBS/mda/fy2025/): filed 2026-02-27; accession 0001367644-26-000015 (https://www.sec.gov/Archives/edgar/data/1367644/000136764426000015/ebs-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/EBS/mda/fy2024/): filed 2025-03-04; accession 0001367644-25-000021 (https://www.sec.gov/Archives/edgar/data/1367644/000136764425000021/ebs-20241231.htm)
- [FY 2023 MD&A](/company/EBS/mda/fy2023/): filed 2024-03-08; accession 0001367644-24-000033 (https://www.sec.gov/Archives/edgar/data/1367644/000136764424000033/ebs-20231231.htm)
- [FY 2022 MD&A](/company/EBS/mda/fy2022/): filed 2023-03-01; accession 0001367644-23-000046 (https://www.sec.gov/Archives/edgar/data/1367644/000136764423000046/ebs-20221231.htm)
- [FY 2021 MD&A](/company/EBS/mda/fy2021/): filed 2022-02-25; accession 0001367644-22-000024 (https://www.sec.gov/Archives/edgar/data/1367644/000136764422000024/ebs-20211231.htm)

Back to /company/EBS/